- Home
- KOD vs CGC Comparison
KOD vs CGC Comparison
Compare KOD & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- CGC
- Stock Information
- Founded
- KOD 2009
- CGC 2009
- Country
- KOD United States
- CGC Canada
- Employees
- KOD N/A
- CGC N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- CGC Pharmaceuticals and Biotechnology
- Sector
- KOD Health Care
- CGC Health Care
- Exchange
- KOD Nasdaq
- CGC Nasdaq
- Market Cap
- KOD 454.7M
- CGC 174.9M
- IPO Year
- KOD 2018
- CGC N/A
- Fundamental
- Price
- KOD $3.45
- CGC $1.05
- Analyst Decision
- KOD Hold
- CGC Sell
- Analyst Count
- KOD 4
- CGC 1
- Target Price
- KOD $8.00
- CGC $2.00
- AVG Volume (30 Days)
- KOD 306.7K
- CGC 7.7M
- Earning Date
- KOD 03-27-2025
- CGC 02-07-2025
- Dividend Yield
- KOD N/A
- CGC N/A
- EPS Growth
- KOD N/A
- CGC N/A
- EPS
- KOD N/A
- CGC N/A
- Revenue
- KOD N/A
- CGC $192,343,833.00
- Revenue This Year
- KOD N/A
- CGC N/A
- Revenue Next Year
- KOD N/A
- CGC $2.50
- P/E Ratio
- KOD N/A
- CGC N/A
- Revenue Growth
- KOD N/A
- CGC N/A
- 52 Week Low
- KOD $2.19
- CGC $1.05
- 52 Week High
- KOD $11.60
- CGC $14.92
- Technical
- Relative Strength Index (RSI)
- KOD 28.84
- CGC 22.81
- Support Level
- KOD $3.59
- CGC $1.07
- Resistance Level
- KOD $3.89
- CGC $1.35
- Average True Range (ATR)
- KOD 0.35
- CGC 0.10
- MACD
- KOD 0.07
- CGC -0.00
- Stochastic Oscillator
- KOD 4.98
- CGC 0.00
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.